APELLIS PHARMACEUTICALS INC

Ticker: APLS CUSIP: 03753U106 Class: Common Stock

Bridgefront Capital, LLC's Holding History (CIK: 0001725690)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 11,326 Value ($000) $285 Avg Close $23.46 Range $18.75 - $30.48

Q1 2025

Shares 29,070 Value ($000) $636 Avg Close $27.62 Range $21.70 - $35.57

Q3 2023

Shares 6,802 Value ($000) $259 Avg Close $43.93 Range $19.83 - $91.35

Q2 2023

Shares 2,627 Value ($000) $239 Avg Close $86.28 Range $73.80 - $94.75

Q2 2021

Shares 3,390 Value ($000) $214 Avg Close $51.60 Range $40.53 - $66.07

Q1 2021

Shares 4,679 Value ($000) $201 Avg Close $47.32 Range $39.95 - $58.47

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	11,326	$285	$23.46	$18.75 - $30.48
Q1 2025	29,070	$636	$27.62	$21.70 - $35.57
Q3 2023	6,802	$259	$43.93	$19.83 - $91.35
Q2 2023	2,627	$239	$86.28	$73.80 - $94.75
Q2 2021	3,390	$214	$51.60	$40.53 - $66.07
Q1 2021	4,679	$201	$47.32	$39.95 - $58.47